Review



trypan blue exclusion cell viability stain  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Thermo Fisher trypan blue exclusion cell viability stain
    BCL6i enhances paclitaxel‐induced breast cancer <t>cell</t> <t>viability</t> and tumor regression. <t>Trypan</t> <t>blue</t> <t>exclusion</t> assay was used to investigate the effect of paclitaxel (7.5 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐231 cells immediately after 24 h of treatment (A) and 72 h of post‐treatment termination (B) ( n = 4). (C) BCL6 expression in a panel of breast cancer cell lines is assessed by qPCR ( n = 4). (D) Trypan blue exclusion assay was used to investigate the effect of 24‐h paclitaxel (3.75 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐468 cells 72 h of post‐treatment termination. (A to D) Error bars represent standard deviation, and significance was determined using one‐way ANOVA (repeated measures) followed by Tukey’s post‐test. (E and F) The effect of intraperitoneal BCL6i and/or paclitaxel treatment (started day 18 postcell injection and ended on day 42) on MDA‐MB‐231 tumors ( n = 12) was assessed by measuring tumor volumes (E) and final tumor weights (F). Error bars represent standard error of the mean. (E) Tumor growth was modeled using simple linear regression and the slopes of the lines compared. The slopes are significantly different from each other ( P value = 0.0031). (F) Significance was determined using one‐way ANOVA followed by Tukey’s post‐test. (A to F) P values are indicated as follows: < 0.05 =*, < 0.01 =**, and < 0.001 =***. [Colour figure can be viewed at wileyonlinelibrary.com ]
    Trypan Blue Exclusion Cell Viability Stain, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trypan blue exclusion cell viability stain/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    trypan blue exclusion cell viability stain - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "An in vivo genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer"

    Article Title: An in vivo genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer

    Journal: Molecular Oncology

    doi: 10.1002/1878-0261.12964

    BCL6i enhances paclitaxel‐induced breast cancer cell viability and tumor regression. Trypan blue exclusion assay was used to investigate the effect of paclitaxel (7.5 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐231 cells immediately after 24 h of treatment (A) and 72 h of post‐treatment termination (B) ( n = 4). (C) BCL6 expression in a panel of breast cancer cell lines is assessed by qPCR ( n = 4). (D) Trypan blue exclusion assay was used to investigate the effect of 24‐h paclitaxel (3.75 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐468 cells 72 h of post‐treatment termination. (A to D) Error bars represent standard deviation, and significance was determined using one‐way ANOVA (repeated measures) followed by Tukey’s post‐test. (E and F) The effect of intraperitoneal BCL6i and/or paclitaxel treatment (started day 18 postcell injection and ended on day 42) on MDA‐MB‐231 tumors ( n = 12) was assessed by measuring tumor volumes (E) and final tumor weights (F). Error bars represent standard error of the mean. (E) Tumor growth was modeled using simple linear regression and the slopes of the lines compared. The slopes are significantly different from each other ( P value = 0.0031). (F) Significance was determined using one‐way ANOVA followed by Tukey’s post‐test. (A to F) P values are indicated as follows: < 0.05 =*, < 0.01 =**, and < 0.001 =***. [Colour figure can be viewed at wileyonlinelibrary.com ]
    Figure Legend Snippet: BCL6i enhances paclitaxel‐induced breast cancer cell viability and tumor regression. Trypan blue exclusion assay was used to investigate the effect of paclitaxel (7.5 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐231 cells immediately after 24 h of treatment (A) and 72 h of post‐treatment termination (B) ( n = 4). (C) BCL6 expression in a panel of breast cancer cell lines is assessed by qPCR ( n = 4). (D) Trypan blue exclusion assay was used to investigate the effect of 24‐h paclitaxel (3.75 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐468 cells 72 h of post‐treatment termination. (A to D) Error bars represent standard deviation, and significance was determined using one‐way ANOVA (repeated measures) followed by Tukey’s post‐test. (E and F) The effect of intraperitoneal BCL6i and/or paclitaxel treatment (started day 18 postcell injection and ended on day 42) on MDA‐MB‐231 tumors ( n = 12) was assessed by measuring tumor volumes (E) and final tumor weights (F). Error bars represent standard error of the mean. (E) Tumor growth was modeled using simple linear regression and the slopes of the lines compared. The slopes are significantly different from each other ( P value = 0.0031). (F) Significance was determined using one‐way ANOVA followed by Tukey’s post‐test. (A to F) P values are indicated as follows: < 0.05 =*, < 0.01 =**, and < 0.001 =***. [Colour figure can be viewed at wileyonlinelibrary.com ]

    Techniques Used: Trypan Blue Exclusion Assay, Expressing, Standard Deviation, Injection



    Similar Products

    trypan blue exclusion cell viability assay  (Millipore)
    90
    Millipore trypan blue exclusion cell viability assay
    Trypan Blue Exclusion Cell Viability Assay, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trypan blue exclusion cell viability assay/product/Millipore
    Average 90 stars, based on 1 article reviews
    trypan blue exclusion cell viability assay - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    trypan blue exclusion cell viability stain  (Thermo Fisher)
    90
    Thermo Fisher trypan blue exclusion cell viability stain
    BCL6i enhances paclitaxel‐induced breast cancer <t>cell</t> <t>viability</t> and tumor regression. <t>Trypan</t> <t>blue</t> <t>exclusion</t> assay was used to investigate the effect of paclitaxel (7.5 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐231 cells immediately after 24 h of treatment (A) and 72 h of post‐treatment termination (B) ( n = 4). (C) BCL6 expression in a panel of breast cancer cell lines is assessed by qPCR ( n = 4). (D) Trypan blue exclusion assay was used to investigate the effect of 24‐h paclitaxel (3.75 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐468 cells 72 h of post‐treatment termination. (A to D) Error bars represent standard deviation, and significance was determined using one‐way ANOVA (repeated measures) followed by Tukey’s post‐test. (E and F) The effect of intraperitoneal BCL6i and/or paclitaxel treatment (started day 18 postcell injection and ended on day 42) on MDA‐MB‐231 tumors ( n = 12) was assessed by measuring tumor volumes (E) and final tumor weights (F). Error bars represent standard error of the mean. (E) Tumor growth was modeled using simple linear regression and the slopes of the lines compared. The slopes are significantly different from each other ( P value = 0.0031). (F) Significance was determined using one‐way ANOVA followed by Tukey’s post‐test. (A to F) P values are indicated as follows: < 0.05 =*, < 0.01 =**, and < 0.001 =***. [Colour figure can be viewed at wileyonlinelibrary.com ]
    Trypan Blue Exclusion Cell Viability Stain, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trypan blue exclusion cell viability stain/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    trypan blue exclusion cell viability stain - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    trypan blue exclusion cell viability assay  (Thermo Fisher)
    90
    Thermo Fisher trypan blue exclusion cell viability assay
    BCL6i enhances paclitaxel‐induced breast cancer <t>cell</t> <t>viability</t> and tumor regression. <t>Trypan</t> <t>blue</t> <t>exclusion</t> assay was used to investigate the effect of paclitaxel (7.5 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐231 cells immediately after 24 h of treatment (A) and 72 h of post‐treatment termination (B) ( n = 4). (C) BCL6 expression in a panel of breast cancer cell lines is assessed by qPCR ( n = 4). (D) Trypan blue exclusion assay was used to investigate the effect of 24‐h paclitaxel (3.75 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐468 cells 72 h of post‐treatment termination. (A to D) Error bars represent standard deviation, and significance was determined using one‐way ANOVA (repeated measures) followed by Tukey’s post‐test. (E and F) The effect of intraperitoneal BCL6i and/or paclitaxel treatment (started day 18 postcell injection and ended on day 42) on MDA‐MB‐231 tumors ( n = 12) was assessed by measuring tumor volumes (E) and final tumor weights (F). Error bars represent standard error of the mean. (E) Tumor growth was modeled using simple linear regression and the slopes of the lines compared. The slopes are significantly different from each other ( P value = 0.0031). (F) Significance was determined using one‐way ANOVA followed by Tukey’s post‐test. (A to F) P values are indicated as follows: < 0.05 =*, < 0.01 =**, and < 0.001 =***. [Colour figure can be viewed at wileyonlinelibrary.com ]
    Trypan Blue Exclusion Cell Viability Assay, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trypan blue exclusion cell viability assay/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    trypan blue exclusion cell viability assay - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    trypan blue exclusion vi cell cell viability analyzer  (Danaher Inc)
    96
    Danaher Inc trypan blue exclusion vi cell cell viability analyzer
    BCL6i enhances paclitaxel‐induced breast cancer <t>cell</t> <t>viability</t> and tumor regression. <t>Trypan</t> <t>blue</t> <t>exclusion</t> assay was used to investigate the effect of paclitaxel (7.5 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐231 cells immediately after 24 h of treatment (A) and 72 h of post‐treatment termination (B) ( n = 4). (C) BCL6 expression in a panel of breast cancer cell lines is assessed by qPCR ( n = 4). (D) Trypan blue exclusion assay was used to investigate the effect of 24‐h paclitaxel (3.75 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐468 cells 72 h of post‐treatment termination. (A to D) Error bars represent standard deviation, and significance was determined using one‐way ANOVA (repeated measures) followed by Tukey’s post‐test. (E and F) The effect of intraperitoneal BCL6i and/or paclitaxel treatment (started day 18 postcell injection and ended on day 42) on MDA‐MB‐231 tumors ( n = 12) was assessed by measuring tumor volumes (E) and final tumor weights (F). Error bars represent standard error of the mean. (E) Tumor growth was modeled using simple linear regression and the slopes of the lines compared. The slopes are significantly different from each other ( P value = 0.0031). (F) Significance was determined using one‐way ANOVA followed by Tukey’s post‐test. (A to F) P values are indicated as follows: < 0.05 =*, < 0.01 =**, and < 0.001 =***. [Colour figure can be viewed at wileyonlinelibrary.com ]
    Trypan Blue Exclusion Vi Cell Cell Viability Analyzer, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trypan blue exclusion vi cell cell viability analyzer/product/Danaher Inc
    Average 96 stars, based on 1 article reviews
    trypan blue exclusion vi cell cell viability analyzer - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    trypan blue exclusion dye assay  (Beyotime)
    99
    Beyotime trypan blue exclusion dye assay
    BCL6i enhances paclitaxel‐induced breast cancer <t>cell</t> <t>viability</t> and tumor regression. <t>Trypan</t> <t>blue</t> <t>exclusion</t> assay was used to investigate the effect of paclitaxel (7.5 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐231 cells immediately after 24 h of treatment (A) and 72 h of post‐treatment termination (B) ( n = 4). (C) BCL6 expression in a panel of breast cancer cell lines is assessed by qPCR ( n = 4). (D) Trypan blue exclusion assay was used to investigate the effect of 24‐h paclitaxel (3.75 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐468 cells 72 h of post‐treatment termination. (A to D) Error bars represent standard deviation, and significance was determined using one‐way ANOVA (repeated measures) followed by Tukey’s post‐test. (E and F) The effect of intraperitoneal BCL6i and/or paclitaxel treatment (started day 18 postcell injection and ended on day 42) on MDA‐MB‐231 tumors ( n = 12) was assessed by measuring tumor volumes (E) and final tumor weights (F). Error bars represent standard error of the mean. (E) Tumor growth was modeled using simple linear regression and the slopes of the lines compared. The slopes are significantly different from each other ( P value = 0.0031). (F) Significance was determined using one‐way ANOVA followed by Tukey’s post‐test. (A to F) P values are indicated as follows: < 0.05 =*, < 0.01 =**, and < 0.001 =***. [Colour figure can be viewed at wileyonlinelibrary.com ]
    Trypan Blue Exclusion Dye Assay, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trypan blue exclusion dye assay/product/Beyotime
    Average 99 stars, based on 1 article reviews
    trypan blue exclusion dye assay - by Bioz Stars, 2026-05
    99/100 stars
    		  Buy from Supplier
    trypan blue exclusion cell viability assay kit  (Millipore)
    90
    Millipore trypan blue exclusion cell viability assay kit
    BCL6i enhances paclitaxel‐induced breast cancer <t>cell</t> <t>viability</t> and tumor regression. <t>Trypan</t> <t>blue</t> <t>exclusion</t> assay was used to investigate the effect of paclitaxel (7.5 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐231 cells immediately after 24 h of treatment (A) and 72 h of post‐treatment termination (B) ( n = 4). (C) BCL6 expression in a panel of breast cancer cell lines is assessed by qPCR ( n = 4). (D) Trypan blue exclusion assay was used to investigate the effect of 24‐h paclitaxel (3.75 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐468 cells 72 h of post‐treatment termination. (A to D) Error bars represent standard deviation, and significance was determined using one‐way ANOVA (repeated measures) followed by Tukey’s post‐test. (E and F) The effect of intraperitoneal BCL6i and/or paclitaxel treatment (started day 18 postcell injection and ended on day 42) on MDA‐MB‐231 tumors ( n = 12) was assessed by measuring tumor volumes (E) and final tumor weights (F). Error bars represent standard error of the mean. (E) Tumor growth was modeled using simple linear regression and the slopes of the lines compared. The slopes are significantly different from each other ( P value = 0.0031). (F) Significance was determined using one‐way ANOVA followed by Tukey’s post‐test. (A to F) P values are indicated as follows: < 0.05 =*, < 0.01 =**, and < 0.001 =***. [Colour figure can be viewed at wileyonlinelibrary.com ]
    Trypan Blue Exclusion Cell Viability Assay Kit, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trypan blue exclusion cell viability assay kit/product/Millipore
    Average 90 stars, based on 1 article reviews
    trypan blue exclusion cell viability assay kit - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    cell viability by trypan blue exclusion  (Millipore)
    90
    Millipore cell viability by trypan blue exclusion
    BCL6i enhances paclitaxel‐induced breast cancer <t>cell</t> <t>viability</t> and tumor regression. <t>Trypan</t> <t>blue</t> <t>exclusion</t> assay was used to investigate the effect of paclitaxel (7.5 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐231 cells immediately after 24 h of treatment (A) and 72 h of post‐treatment termination (B) ( n = 4). (C) BCL6 expression in a panel of breast cancer cell lines is assessed by qPCR ( n = 4). (D) Trypan blue exclusion assay was used to investigate the effect of 24‐h paclitaxel (3.75 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐468 cells 72 h of post‐treatment termination. (A to D) Error bars represent standard deviation, and significance was determined using one‐way ANOVA (repeated measures) followed by Tukey’s post‐test. (E and F) The effect of intraperitoneal BCL6i and/or paclitaxel treatment (started day 18 postcell injection and ended on day 42) on MDA‐MB‐231 tumors ( n = 12) was assessed by measuring tumor volumes (E) and final tumor weights (F). Error bars represent standard error of the mean. (E) Tumor growth was modeled using simple linear regression and the slopes of the lines compared. The slopes are significantly different from each other ( P value = 0.0031). (F) Significance was determined using one‐way ANOVA followed by Tukey’s post‐test. (A to F) P values are indicated as follows: < 0.05 =*, < 0.01 =**, and < 0.001 =***. [Colour figure can be viewed at wileyonlinelibrary.com ]
    Cell Viability By Trypan Blue Exclusion, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell viability by trypan blue exclusion/product/Millipore
    Average 90 stars, based on 1 article reviews
    cell viability by trypan blue exclusion - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    BCL6i enhances paclitaxel‐induced breast cancer cell viability and tumor regression. Trypan blue exclusion assay was used to investigate the effect of paclitaxel (7.5 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐231 cells immediately after 24 h of treatment (A) and 72 h of post‐treatment termination (B) ( n = 4). (C) BCL6 expression in a panel of breast cancer cell lines is assessed by qPCR ( n = 4). (D) Trypan blue exclusion assay was used to investigate the effect of 24‐h paclitaxel (3.75 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐468 cells 72 h of post‐treatment termination. (A to D) Error bars represent standard deviation, and significance was determined using one‐way ANOVA (repeated measures) followed by Tukey’s post‐test. (E and F) The effect of intraperitoneal BCL6i and/or paclitaxel treatment (started day 18 postcell injection and ended on day 42) on MDA‐MB‐231 tumors ( n = 12) was assessed by measuring tumor volumes (E) and final tumor weights (F). Error bars represent standard error of the mean. (E) Tumor growth was modeled using simple linear regression and the slopes of the lines compared. The slopes are significantly different from each other ( P value = 0.0031). (F) Significance was determined using one‐way ANOVA followed by Tukey’s post‐test. (A to F) P values are indicated as follows: < 0.05 =*, < 0.01 =**, and < 0.001 =***. [Colour figure can be viewed at wileyonlinelibrary.com ]

    Journal: Molecular Oncology

    Article Title: An in vivo genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer

    doi: 10.1002/1878-0261.12964

    Figure Lengend Snippet: BCL6i enhances paclitaxel‐induced breast cancer cell viability and tumor regression. Trypan blue exclusion assay was used to investigate the effect of paclitaxel (7.5 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐231 cells immediately after 24 h of treatment (A) and 72 h of post‐treatment termination (B) ( n = 4). (C) BCL6 expression in a panel of breast cancer cell lines is assessed by qPCR ( n = 4). (D) Trypan blue exclusion assay was used to investigate the effect of 24‐h paclitaxel (3.75 n m ) and/or BCL6i (50 µ m ) treatment on the number of viable MDA‐MB‐468 cells 72 h of post‐treatment termination. (A to D) Error bars represent standard deviation, and significance was determined using one‐way ANOVA (repeated measures) followed by Tukey’s post‐test. (E and F) The effect of intraperitoneal BCL6i and/or paclitaxel treatment (started day 18 postcell injection and ended on day 42) on MDA‐MB‐231 tumors ( n = 12) was assessed by measuring tumor volumes (E) and final tumor weights (F). Error bars represent standard error of the mean. (E) Tumor growth was modeled using simple linear regression and the slopes of the lines compared. The slopes are significantly different from each other ( P value = 0.0031). (F) Significance was determined using one‐way ANOVA followed by Tukey’s post‐test. (A to F) P values are indicated as follows: < 0.05 =*, < 0.01 =**, and < 0.001 =***. [Colour figure can be viewed at wileyonlinelibrary.com ]

    Article Snippet: Viable cells were then collected and counted using Trypan Blue exclusion cell viability stain (Thermo Fisher Scientific) or continued to be cultured for another 72 h (without treatment) and then collected and counted, and viable cell numbers were calculated relative to the no‐treatment controls.

    Techniques: Trypan Blue Exclusion Assay, Expressing, Standard Deviation, Injection